BioMed Research International / 2015 / Article / Tab 2 / Clinical Study
Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients Table 2 Patient characteristics.
Group A (N = 16) Group B (N = 16) Group C (N = 15) Age (years) 60.6 ± 10.5 57.0 ± 11.3 60.9 ± 17.6 Sex (male : female) 5 : 11 3 : 13 4 : 11 Height (cm) 161.3 ± 6.5 156.6 ± 7.0 159.9 ± 6.5 Weight (kg) 59.9 ± 8.7 55.4 ± 8.4 63.7 ± 9.7 ASA PS status 1.56 ± 0.51 1.63 ± 0.5 1.73 ± 0.5 Apfel’s PONV risk [1 ] 3.31 ± 0.95 3.38 ± 0.81 3.00 ± 0.85
The values are shown as means ± SD or numbers of patients. ASA PS: American Society of Anesthesiology Physical Status. PONV: Postoperative nausea and vomiting.